Peripheral T-Cell Lymphoma: Time for a T-Cell–Centric Standard of Care

This is an exciting time in the treatment of PTCL, but with this opportunity comes responsibility. The challenge of how to optimize a plethora of promising new therapies for a small number of patients will drive therapeutic decision making for the foreseeable future.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news